[Acute coronary syndrome: ST-segment elevation infarct]
Kurt J Schmailzl1, Frank Hölschermann, Torsten Schwalm
1Medizinischee Klinik A, Schwerpunkt Kardiologie/Pneumologie mit Nephrologie/Dialyse und internistischer Intensivmedizin, Deutschland. k.schmailzl@ruppiner-kliniken.de
Insights
This review focuses on ST-segment elevation myocardial infarction (STEMI) management, exploring recent therapeutic advancements and evidence. It discusses contemporary antithrombotic strategies and the invasive versus conservative treatment debate for acute coronary syndrome (ACS).
Area of Science:
- Cardiology
- Internal Medicine
- Emergency Medicine
Background:
- Management of ST-segment elevation myocardial infarction (STEMI) has seen significant evolution.
- Contemporary treatment strategies require careful consideration of evidence and accessibility.
Purpose of the Study:
- To review recent developments and insights in STEMI therapeutic options.
- To discuss the current antithrombotic approach for STEMI.
- To explore the invasive versus conservative treatment controversy in acute coronary syndrome (ACS).
Main Methods:
- Literature review of recent therapeutic options for STEMI.
- Analysis of evidence supporting various treatment modalities.
- Discussion of cost-benefit considerations in treatment assessment.
Main Results:
- Recent advancements offer new therapeutic avenues for STEMI.
- Contemporary antithrombotic strategies are crucial for STEMI management.
- The debate between invasive and conservative ACS treatment persists due to study limitations and therapy availability.
Conclusions:
- Evidence-based management of STEMI continues to evolve.
- Optimal ACS treatment requires balancing efficacy, cost, and accessibility.
- Further research is needed to clarify treatment controversies.
Abstract:
Management of acute myocardial infarction in patients presenting with ST-segment elevation has evolved considerably over the past decades. In this review, we will limit the discussion to STEMI, and describe some recent developments and new insights into the evidence base of various therapeutic options. We will address the contemporary antithrombotic approach to treatment of this disorder. The controversy regarding optimal treatment of ACS, whether invasive or conservative, is discussed. This seems all the mandatory more as many study populations are not directly comparable, and some therapies are nowhere at hand. Progressively important cost-benefit considerations are another aspect that makes the assessment of the evidence claimed difficult.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Angina II: Classification


